Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ibuprofen premedication for pain during pulp therapy in mandibular primary molars
IRCT20200304046693N1Phase 3Completed
- Sponsor
- Qazvin University of Medical Sciences
- Start
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, triple-blind trial in pulpitis comparing Ibuprofen premedication with Placebo premedication (2 arms). Primary endpoint: Pain during pulp therapy. Started Apr 2019; status: completed.
02
Drugs
ibuprofen
03
Conditions
pulpitis
Beyond the preview
Go deeper on IRCT20200304046693N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200304046693N1.